Stay updated on Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a small update to the page's revision metadata. No user-visible content changes are reflected by this update.
    Difference
    0.1%
    Check dated 2026-05-15T04:57:28.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision label was updated to Revision: v3.5.3, indicating a small system update behind the scenes.
    Difference
    0.1%
    Check dated 2026-04-30T16:37:16.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Added UI revision tag 'Revision: v3.5.2' and removed 'Revision: v3.5.0'.
    Difference
    0.1%
    Check dated 2026-04-16T10:23:45.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added a new Publications entry: Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial (Blood, 2026).
    Difference
    0.1%
    Check dated 2026-04-09T07:55:23.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-25T20:34:00.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T15:18:55.000Z thumbnail image

Stay in the know with updates to Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab AVD in Early Unfavorable Hodgkin Lymphoma Clinical Trial page.